stars 1 stars 2 stars 3

We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Our mission in Biomendex is to change the way bone voids are treated. We believe that delivering versatile and better working medical devices to operating theaters is an essential factor in improving surgical outcomes and minimizing the operational risks in bone regeneration. We believe in freedom to operate.

Biomendex Questions

Kaarlo Paakinaho is the Founder of Biomendex.

9 people are employed at Biomendex.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users